Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology behind anticonvulsant osteomalacia.

C Christiansen, P Rødbro, L Tjellesen

    Acta Neurologica Scandinavica. Supplementum
    |January 1, 1983
    PubMed
    Summary

    Anticonvulsant drugs can cause osteomalacia by disrupting vitamin D metabolism, leading to bone density loss. While vitamin D supplements can help, preventive treatment is not generally recommended for this mild condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies.

    Clinical chemistry·1995
    Same author

    Body composition and serum lipids in female runners: influence of exercise level and menstrual bleeding pattern.

    European journal of clinical investigation·1995
    Same author

    Changes in the carboxyl-terminal propeptide of type I procollagen and other markers of bone formation upon five days of bed rest.

    Bone·1995
    Same author

    Measurement of bone mineral density.

    Calcified tissue international·1995
    Same author

    Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·1995
    Same author

    [The osteoporosis profile].

    Ugeskrift for laeger·1995

    Area of Science:

    • Endocrinology
    • Metabolic Bone Disease

    Background:

    • Anticonvulsant medications are known to induce disorders affecting mineral and bone metabolism.
    • A specific condition, 'anticonvulsant osteomalacia,' is characterized by hypocalcaemia, elevated alkaline phosphatase, and reduced 25-hydroxycholecalciferol (25 OHD3).

    Purpose of the Study:

    • To discuss anticonvulsant drug-induced disorders in mineral and bone metabolism.
    • To explore the pathophysiological mechanisms and treatment effects of vitamin D in anticonvulsant osteomalacia.

    Main Methods:

    • Review of literature on anticonvulsant drug effects on bone metabolism.
    • Analysis of studies investigating vitamin D supplementation (D2, D3, 25 OHD3) in affected patients.

    Main Results:

    • Anticonvulsant osteomalacia involves vitamin D deficiency due to liver enzyme induction disrupting vitamin D metabolism.
    • Vitamin D2 treatment increased bone mineral content (BMC) but not serum calcium.
    • Vitamin D3 or 25 OHD3 increased serum calcium but did not alter BMC.
    • Findings suggest differential metabolism of vitamin D2 and D3 in patients on anticonvulsants.

    Conclusions:

    • Anticonvulsant-induced osteomalacia is a condition linked to altered vitamin D metabolism.
    • Vitamin D2 and D3 exhibit distinct metabolic pathways and effects in patients treated with anticonvulsants.
    • Current evidence does not support routine preventive treatment for this condition.

    Related Experiment Videos